Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Journal of Molecular Biology
|
May 5, 1992
Both forms of translational initiation factor IF2 (alpha and beta) are required for maximal growth of Escherichia coli. Evidence for two translational initiation codons for IF2 beta
C Sacerdot, G Vachon, S Laalami, et al.
The Journal of Biological Chemistry
|
February 26, 1999
In vitro study of two dominant inhibitory GTPase mutants of Escherichia coli translation initiation factor IF2. Direct evidence that GTP hydrolysis is necessary for factor recycling
S Luchin, H Putzer, J W Hershey, et al.
Biochimie
|
July 1, 1991
Superexpression and fast purification of E coli initiation factor IF2
K K Mortensen, N R Nyengaard, J W Hershey, et al.
Drugs Under Experimental and Clinical Research
|
January 1, 1987
Rational design of bis-intercalating drugs as antitumour agents: importance of rigidity in the linking chain
C Garbay-Jaureguiberry, C Esnault, M Delepierre, et al.
The Journal of Biological Chemistry
|
September 13, 1996
Interplay of methionine tRNAs with translation elongation factor Tu and translation initiation factor 2 in Escherichia coli
J M Guillon, S Heiss, J Soutourina, et al.
RNA (New York, N.Y.)
|
August 13, 1998
Release factor RF-3 GTPase activity acts in disassembly of the ribosome termination complex
G Grentzmann, P J Kelly, S Laalami, et al.
Biochemistry
|
March 5, 1996
Topography of the Escherichia coli initiation factor 2/fMet-tRNA(f)(Met) complex as studied by cross-linking
G Yusupova, J Reinbolt, H Wakao, et al.
Biochimie
|
December 1, 1991
Structural and functional domains of E coli initiation factor IF2
S Laalami, C Sacerdot, G Vachon, et al.
The Journal of Biological Chemistry
|
December 5, 1989
The solution structure of the Escherichia coli initiator tRNA and its interactions with initiation factor 2 and the ribosomal 30 S subunit
H Wakao, P Romby, E Westhof, et al.
Anti-Cancer Drug Design
|
April 1, 1987
DNA bis-intercalators as new anti-tumour agents: modulation of the anti-tumour activity by the linking chain rigidity in the ditercalinium series
C Garbay-Jaureguiberry, P Laugâa, M Delepierre, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Journal of Molecular Biology
|
May 5, 1992
Both forms of translational initiation factor IF2 (alpha and beta) are required for maximal growth of Escherichia coli. Evidence for two translational initiation codons for IF2 beta
C Sacerdot, G Vachon, S Laalami, et al.
The Journal of Biological Chemistry
|
February 26, 1999
In vitro study of two dominant inhibitory GTPase mutants of Escherichia coli translation initiation factor IF2. Direct evidence that GTP hydrolysis is necessary for factor recycling
S Luchin, H Putzer, J W Hershey, et al.
Biochimie
|
July 1, 1991
Superexpression and fast purification of E coli initiation factor IF2
K K Mortensen, N R Nyengaard, J W Hershey, et al.
Drugs Under Experimental and Clinical Research
|
January 1, 1987
Rational design of bis-intercalating drugs as antitumour agents: importance of rigidity in the linking chain
C Garbay-Jaureguiberry, C Esnault, M Delepierre, et al.
The Journal of Biological Chemistry
|
September 13, 1996
Interplay of methionine tRNAs with translation elongation factor Tu and translation initiation factor 2 in Escherichia coli
J M Guillon, S Heiss, J Soutourina, et al.
RNA (New York, N.Y.)
|
August 13, 1998
Release factor RF-3 GTPase activity acts in disassembly of the ribosome termination complex
G Grentzmann, P J Kelly, S Laalami, et al.
Biochemistry
|
March 5, 1996
Topography of the Escherichia coli initiation factor 2/fMet-tRNA(f)(Met) complex as studied by cross-linking
G Yusupova, J Reinbolt, H Wakao, et al.
Biochimie
|
December 1, 1991
Structural and functional domains of E coli initiation factor IF2
S Laalami, C Sacerdot, G Vachon, et al.
The Journal of Biological Chemistry
|
December 5, 1989
The solution structure of the Escherichia coli initiator tRNA and its interactions with initiation factor 2 and the ribosomal 30 S subunit
H Wakao, P Romby, E Westhof, et al.
Anti-Cancer Drug Design
|
April 1, 1987
DNA bis-intercalators as new anti-tumour agents: modulation of the anti-tumour activity by the linking chain rigidity in the ditercalinium series
C Garbay-Jaureguiberry, P Laugâa, M Delepierre, et al.
Page
of 3